Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
News|Podcasts|March 30, 2026
Ashwa.30™: Insights on Aging and Longevity
Author(s)AIDP
In this episode, Dr. Bharathi B, from Natural Remedies, discusses the science behind Ashwa.30™, a next-generation, bioactive-optimized ashwagandha extract formulated to deliver clinical efficacy at just 30 mg per day. She explains how its dual standardization to withanolides and a proprietary ATP-active fraction broadens adaptogenic support beyond conventional extracts, and how human clinical trials, metabolomic insights, and biomarker data support its role in promoting cellular health for healthy ageing and longevity.
Advertisement
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
2
Thirty Years of GCP: The Evolution From Study Execution to Evidence Generation
3
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
4
Study of SRI-81 Shatavari Reports Sexual Function Gains Versus Placebo in Women
5